Agus Michael S D, Wypij David, Hirshberg Eliotte L, Srinivasan Vijay, Faustino E Vincent, Luckett Peter M, Alexander Jamin L, Asaro Lisa A, Curley Martha A Q, Steil Garry M, Nadkarni Vinay M
From the Division of Medicine Critical Care (M.S.D.A., J.L.A., G.M.S.) and the Department of Cardiology (D.W., L.A.A.), Boston Children's Hospital and Harvard Medical School, Boston; the Division of Pediatric Critical Care, University of Utah Medical School, Primary Children's Hospital, Salt Lake City, and Intermountain Medical Center, Murray - both in Utah (E.L.H.); Children's Hospital of Philadelphia (V.S., V.M.N.) and the Perelman School of Medicine (V.S., M.A.Q.C., V.M.N.) and the School of Nursing (M.A.Q.C.), University of Pennsylvania - all in Philadelphia; Yale School of Medicine, New Haven, CT (E.V.F.); and Children's Medical Center Dallas and the University of Texas Southwestern Medical School, Dallas (P.M.L.).
N Engl J Med. 2017 Feb 23;376(8):729-741. doi: 10.1056/NEJMoa1612348. Epub 2017 Jan 24.
In multicenter studies, tight glycemic control targeting a normal blood glucose level has not been shown to improve outcomes in critically ill adults or children after cardiac surgery. Studies involving critically ill children who have not undergone cardiac surgery are lacking.
In a 35-center trial, we randomly assigned critically ill children with confirmed hyperglycemia (excluding patients who had undergone cardiac surgery) to one of two ranges of glycemic control: 80 to 110 mg per deciliter (4.4 to 6.1 mmol per liter; lower-target group) or 150 to 180 mg per deciliter (8.3 to 10.0 mmol per liter; higher-target group). Clinicians were guided by continuous glucose monitoring and explicit methods for insulin adjustment. The primary outcome was the number of intensive care unit (ICU)-free days to day 28.
The trial was stopped early, on the recommendation of the data and safety monitoring board, owing to a low likelihood of benefit and evidence of the possibility of harm. Of 713 patients, 360 were randomly assigned to the lower-target group and 353 to the higher-target group. In the intention-to-treat analysis, the median number of ICU-free days did not differ significantly between the lower-target group and the higher-target group (19.4 days [interquartile range {IQR}, 0 to 24.2] and 19.4 days [IQR, 6.7 to 23.9], respectively; P=0.58). In per-protocol analyses, the median time-weighted average glucose level was significantly lower in the lower-target group (109 mg per deciliter [IQR, 102 to 118]; 6.1 mmol per liter [IQR, 5.7 to 6.6]) than in the higher-target group (123 mg per deciliter [IQR, 108 to 142]; 6.8 mmol per liter [IQR, 6.0 to 7.9]; P<0.001). Patients in the lower-target group also had higher rates of health care-associated infections than those in the higher-target group (12 of 349 patients [3.4%] vs. 4 of 349 [1.1%], P=0.04), as well as higher rates of severe hypoglycemia, defined as a blood glucose level below 40 mg per deciliter (2.2 mmol per liter) (18 patients [5.2%] vs. 7 [2.0%], P=0.03). No significant differences were observed in mortality, severity of organ dysfunction, or the number of ventilator-free days.
Critically ill children with hyperglycemia did not benefit from tight glycemic control targeted to a blood glucose level of 80 to 110 mg per deciliter, as compared with a level of 150 to 180 mg per deciliter. (Funded by the National Heart, Lung, and Blood Institute and others; HALF-PINT ClinicalTrials.gov number, NCT01565941 .).
在多中心研究中,针对正常血糖水平进行严格血糖控制尚未被证明能改善成年或儿童心脏手术后重症患者的预后。目前缺乏针对未接受心脏手术的重症儿童的研究。
在一项35中心试验中,我们将确诊为高血糖的重症儿童(不包括接受过心脏手术的患者)随机分配至两个血糖控制范围之一:80至110毫克/分升(4.4至6.1毫摩尔/升;低目标组)或150至180毫克/分升(8.3至10.0毫摩尔/升;高目标组)。临床医生通过持续血糖监测和明确的胰岛素调整方法进行指导。主要结局是至第28天无重症监护病房(ICU)天数。
根据数据和安全监测委员会的建议,该试验提前终止,因为获益可能性低且有伤害可能性的证据。713例患者中,360例被随机分配至低目标组,353例被随机分配至高目标组。在意向性分析中,低目标组和高目标组的无ICU天数中位数无显著差异(分别为19.4天[四分位间距{IQR},0至24.2]和19.4天[IQR,6.7至23.9];P = 0.58)。在符合方案分析中,低目标组的时间加权平均血糖水平中位数(109毫克/分升[IQR,102至118];6.1毫摩尔/升[IQR,5.7至6.6])显著低于高目标组(123毫克/分升[IQR,108至142];6.8毫摩尔/升[IQR,6.0至7.9];P<0.001)。低目标组患者的医疗相关感染发生率也高于高目标组(349例患者中12例[3.4%]对349例中4例[1.1%],P = 0.04),以及严重低血糖发生率更高,严重低血糖定义为血糖水平低于40毫克/分升(2.2毫摩尔/升)(18例患者[5.2%]对7例[2.0%],P = 0.03)。在死亡率、器官功能障碍严重程度或无呼吸机天数方面未观察到显著差异。
与血糖水平控制在150至180毫克/分升相比,血糖水平控制在80至110毫克/分升的高血糖重症儿童未从严格血糖控制中获益。(由美国国立心肺血液研究所及其他机构资助;HALF-PINT临床试验注册号,NCT01565941。)